A DNA aptamer targeting cellular fibronectin rather than plasma fibronectin for bioimaging and targeted chemotherapy of tumors
10.1002/adfm.202205002 · doi-reference
Fibronectin forms the most extensible biological fibers displaying switchable force-exposed cryptic binding sites
10.1073/pnas.0907518106 · doi-reference
Dynamic structure of plasma fibronectin
10.1080/10409238.2016.1184224 · doi-reference
A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived
10.1074/jbc.m611315200 · doi-reference
Pre-metastatic niches: Organ-specific homes for metastases
10.1038/nrc.2017.6 · doi-reference
Recent advances in nanotechnology-based drug delivery systems for the kidney
10.1016/j.jconrel.2020.02.027 · doi-reference
Disturbed flow-facilitated margination and targeting of nanodisks protect against atherosclerosis
10.1002/smll.202204694 · doi-reference
Nanomedicines for renal disease: Current status and future applications
10.1038/nrneph.2016.156 · doi-reference
TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α
10.1016/j.bcp.2021.114527 · doi-reference
10.1038/s41388-020-01499-2
10.1038/s41388-020-01499-2 · doi-reference
Extracellular matrix in the tumor microenvironment and its impact on cancer therapy
10.3389/fmolb.2019.00160 · doi-reference
Vasculogenic mimicry formation in EBV-associated epithelial malignancies
10.1038/s41467-018-07308-5 · doi-reference
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
10.1007/s10456-011-9213-5 · doi-reference
Nitric oxide-loaded bioinspired lipoprotein normalizes tumor vessels to improve intratumor delivery and chemotherapy of albumin-bound paclitaxel nanoparticles
10.1021/acs.nanolett.2c04312 · doi-reference
Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines
10.1158/2326-6066.cir-14-0076 · doi-reference
Androgen deprivation therapy for prostate cancer
10.1001/jama.294.2.238 · doi-reference
Breaking physical barrier of fibrotic breast cancer for photodynamic immunotherapy by remodeling tumor extracellular matrix and reprogramming cancer-associated fibroblasts
10.1021/acsnano.4c01499 · doi-reference
Targeted reprogramming of vitamin B3 metabolism as a nanotherapeutic strategy towards chemoresistant cancers
10.1002/adma.202301257 · doi-reference
Precision targeted cancer-associated fibroblast nano-regulator enhanced chemo-immunotherapy for triple-negative breast cancer
10.1016/j.biomaterials.2025.123679 · doi-reference
Reshaping prostate tumor microenvironment to suppress metastasis via cancer-associated fibroblast inactivation with peptide-assembly-based nanosystem
10.1021/acsnano.9b04857 · doi-reference
Luteolin and glycyrrhetinic exert cooperative effect on liver cancer by selfassembling into carrier-free nanostructures
10.1016/j.cclet.2025.111325 · doi-reference
Cancer-associated fibroblast-targeted delivery of captopril to overcome penetration obstacles for enhanced pancreatic cancer therapy
10.1021/acsabm.2c00486 · doi-reference
Cascade drug delivery through tumor barriers of pancreatic cancer via ultrasound in combination with functional microbubbles
10.1021/acsbiomaterials.2c00069 · doi-reference
Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles
10.1016/j.biomaterials.2014.01.046 · doi-reference
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds
10.1073/pnas.0511219103 · doi-reference
A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI
10.1021/bc800211r · doi-reference
